Pharming Group to participate in September investor conferences
Pharming plans New York investor conference appearances in mid-September, with its CEO’s September 14 presentation streamed live and on replay online.
Rhea-AI Summary
Pharming Group (PHARM) will participate in two investor conferences in New York in September 2026, including the H.C. Wainwright 28th Annual Global Investment Conference on September 14 and the Morgan Stanley 24th Annual Global Healthcare Conference on September 15.
Chief Executive Officer Fabrice Chouraqui will present at H.C. Wainwright on Monday, September 14 at 09:30 EDT/15:30 CEST. A live webcast and replay of this presentation will be available in the “Events and presentations” and “Our news” sections of Pharming’s website.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced that its management will participate in the following investor conferences in the month of September:
- H.C. Wainwright 28th Annual Global Investment Conference, New York, September 14, 2026
Fabrice Chouraqui, Chief Executive Officer, will present on Monday, September 14 at 09:30 EDT/15:30 CEST. A live webcast and replay of the presentation will be made available in the “Events and presentations” and “Our news” sections of Pharming’s website. - Morgan Stanley 24th Annual Global Healthcare Conference, New York, September 15, 2026
For more information about these conferences, or to schedule a one-on-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your H.C. Wainwright or Morgan Stanley representative.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We develop and commercialize a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with U.S. and European operations.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming
Michael Levitan, VP Investor Relations & Capital Markets
T: +1 (908) 705 1696
E: investor@pharming.com
Saskia Mehring, Head of Corporate Communications
T: +31 6 28 32 60 41
E: media.relations@pharming.com
Media Relations
Julia Deutsch (Lyra Strategic Advisory on behalf of Pharming)
E: JDeutsch@lyraadvisory.com
Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)
T: +31 6 53 81 64 27
Attachment
FAQ
How can investors access the Pharming presentation at the H.C. Wainwright conference?
A live webcast and replay of Fabrice Chouraqui’s September 14 presentation at the H.C. Wainwright 28th Annual Global Investment Conference will be available in the “Events and presentations” and “Our news” sections of Pharming’s website.
How can investors arrange one-on-one meetings with Pharming’s management around these conferences?
To schedule a one-on-one meeting with Pharming’s management team for either the H.C. Wainwright or Morgan Stanley conferences, investors are instructed to contact Pharming’s Investor Relations team at investor@pharming.com or reach out to their H.C. Wainwright or Morgan Stanley representative.